PTC Therapeutics Reports Inducement Grants Under Nasdaq Rule 5635(c)(4)

PTC Therapeutics approved stock options and 11,535 restricted stock units on Oct. 28, 2026, under Nasdaq’s inducement-grant exemption. The option count is reported as 9.620 in the source.